Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study

Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study

Abstract Background To investigate efficacy and safety of intravenous abatacept in Japanese patients with active polyarticular-course juvenile idiopathic arthritis (pJIA). Methods In this phase III, open-label, multicenter, single-arm study, patients with pJIA aged 4–17 years who failed ≥1 biologic...

Full description

Bibliographic Details
Main Authors: Ryoki Hara, Hiroaki Umebayashi, Syuji Takei, Nami Okamoto, Naomi Iwata, Yuichi Yamasaki, Yasuo Nakagishi, Toshitaka Kizawa, Ichiro Kobayashi, Tomoyuki Imagawa, Noriko Kinjo, Norihito Amano, Yoko Takahashi, Masaaki Mori, Yasuhiko Itoh, Shumpei Yokota
Format: Article
Language:English
Published: BMC 2019-04-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Abatacept
Disease-modifying anti-rheumatic drugs (DMARDs)
Japanese
Juvenile idiopathic arthritis
Pharmacokinetics
Online Access:http://link.springer.com/article/10.1186/s12969-019-0319-4

Internet

http://link.springer.com/article/10.1186/s12969-019-0319-4

Similar Items